AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1308025 — intervention group
Group type: COMPARATOR
Intervention: Biuret method
Number of subjects: 102
Study 3898847 — intervention group
Group type: EXPERIMENTAL
Intervention: Single preoperative intramuscular dose of cefoxitin (2 gm)
Number of subjects: 50
Study 3898847 — intervention group
Group type: COMPARATOR
Intervention: Two or three doses of cefoxitin (2 gm)
Number of subjects: 50
Study 29220105 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and coenzyme Q10 supplementation
Number of subjects: 122
Study 29220105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 26967693 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinvitation letter and reminder sent 6 and 3 weeks before the new colonoscopy appointment date.
Number of subjects: 1000
Study 26967693 — intervention group
Group type: COMPARATOR
Intervention: Invitation to an educational meeting sent 6 weeks before the meeting date.
Number of subjects: 1000
Study 24911368 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (n = 249)
Number of subjects: 498
Study 24911368 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 245)
Number of subjects: 498
Study 22738801 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d.
Number of subjects: 870
Study 22738801 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea
Number of subjects: 870
Study 22738801 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 870
Study 20410149 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation exercise intervention over a 16-week period
Number of subjects: 91
Study 20410149 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy age-, gender-, and dwelling-matched individuals)
Number of subjects: 91
Study 20410149 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight transfer onto the affected leg during rehabilitation
Number of subjects: 91
Study 19463340 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront thrombus aspiration
Number of subjects: 355
Study 19463340 — intervention group
Group type: COMPARATOR
Intervention: Conventional primary PCI
Number of subjects: 355
Study 15978268 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - acid+primer+adhesive
Number of subjects: 25
Study 15978268 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 - only primer
Number of subjects: 25
Study 15978268 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 - only bonding resin (light-cured for 10s)
Number of subjects: 25
Study 15978268 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 - only composite resin (light-cured for 40s)
Number of subjects: 25
Study 15978268 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 5 - calcium hydroxide
Number of subjects: 25
Study 12024138 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclip placement
Number of subjects: 35
Study 12024138 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic epinephrine injection
Number of subjects: 35
Study 10417603 — intervention group
Group type: EXPERIMENTAL
Intervention: medicolegal curriculum
Number of subjects: 64
Study 10417603 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 64
Study 7574325 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-layer transversalis fascia repair
Number of subjects: 87
Study 7574325 — intervention group
Group type: COMPARATOR
Intervention: Four-layer Shouldice repair
Number of subjects: 87
Study 1675315 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/day aspirin
Number of subjects: 323
Study 1675315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study 6447272 — intervention group
Group type: EXPERIMENTAL
Intervention: Mega-doses of vitamin E
Number of subjects: 1
Study 6447272 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1
Study 30536496 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 311
Study 30536496 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 311
Study 29085004 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal exercise training
Number of subjects: 24
Study 26353787 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information provision about cancer related sexual changes (self-help condition; SH)
Number of subjects: 141
Study 26353787 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information accompanied by a single session of counselling (health professional condition; HP)
Number of subjects: 141
Study 24283222 — intervention group
Group type: EXPERIMENTAL
Intervention: First- and second-generation antipsychotics
Number of subjects: 399
Study 21338276 — intervention group
Group type: COMPARATOR
Intervention: Tetradecylthioacetic acid (TTA) 1000 mg daily for 28 days
Number of subjects: 0
Study 19762678 — intervention group
Group type: EXPERIMENTAL
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 22
Study 19762678 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 22
Study 17519543 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) given orally
Number of subjects: 90
Study 17519543 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) in vitro
Number of subjects: 90
Study 17519543 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelets from stroke patients
Number of subjects: 90
Study 17519543 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (N=25)
Number of subjects: 90
Study 15728132 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon as an anaesthetic
Number of subjects: 0
Study 11498264 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1beta and IL-1ra polymorphisms in MS patients
Number of subjects: 98
Study 9529766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (100% oxygen, pressure)
Number of subjects: 0
Study 9529766 — intervention group
Group type: COMPARATOR
Intervention: Control (100% oxygen, no pressure)
Number of subjects: 0
Study 9529766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment
Number of subjects: 0
Study 9529766 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 7994204 — intervention group
Group type: EXPERIMENTAL
Intervention: fibre-optic sensor
Number of subjects: 10
Study 7994204 — intervention group
Group type: COMPARATOR
Intervention: mercury strain-gauge sensor
Number of subjects: 10
Study 2690970 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic adjuvant therapy
Number of subjects: 0
Study 769597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent assisted ventilation using the Retec breathing assistor
Number of subjects: 6
Study 31786934 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.71 mg/kg)
Number of subjects: 40
Study 31786934 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.025 mg/kg)
Number of subjects: 40
Study 30918134 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 μg b.i.d.) for 12 weeks
Number of subjects: 182
Study 30918134 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1,000 mg b.i.d.) for 12 weeks
Number of subjects: 182
Study 30918134 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 182
Study 28343364 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning aerobic exercise for 6 weeks
Number of subjects: 48
Study 28343364 — intervention group
Group type: COMPARATOR
Intervention: Evening aerobic exercise for 6 weeks
Number of subjects: 48
Study 25736957 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip strengthening exercises
Number of subjects: 30
Study 25736957 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip rotation stretching exercises
Number of subjects: 30
Study 25736957 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-directional hip stretching exercises
Number of subjects: 30
Study 23887741 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan infusion at 0.1 μg/kg/min, every 30 days
Number of subjects: 213
Study 23887741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 21145540 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy to diagnose endometriosis, assessment by neurologist to assess headaches
Number of subjects: 108
Study 19175042 — intervention group
Group type: EXPERIMENTAL
Intervention: ThermoStapler vessel sealing system (n = 60)
Number of subjects: 120
Study 19175042 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical technique (n = 60)
Number of subjects: 120
Study 17121211 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 60 mg once a day
Number of subjects: 0
Study 17121211 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 60 mg/day
Number of subjects: 0
Study 17121211 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine
Number of subjects: 0
Study 12826965 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 60
Study 12826965 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 60
Study 10694193 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (15 g/day)
Number of subjects: 17
Study 10694193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 9017786 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic agents that reduce leukotriene activity or enhance prostaglandin activity, or agents that do both; specific agents not detailed.
Number of subjects: 0
Study 9017786 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-agonists and cromolyn sodium; specific dosages and durations not mentioned.
Number of subjects: 0
Study 8446805 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate models for crossover designs
Number of subjects: 0
Study 8446805 — intervention group
Group type: COMPARATOR
Intervention: Univariate methods
Number of subjects: 0
Study 3511772 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 21
Study 3511772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 28598590 — intervention group
Group type: EXPERIMENTAL
Intervention: Corega group (CG)
Number of subjects: 81
Study 28598590 — intervention group
Group type: EXPERIMENTAL
Intervention: Renew group (RG)
Number of subjects: 81
Study 28598590 — intervention group
Group type: COMPARATOR
Intervention: Distilled water group (DWG)
Number of subjects: 81
Study 28913920 — intervention group
Group type: EXPERIMENTAL
Intervention: Dramatic pretend play games
Number of subjects: 97
Study 28913920 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 97
Study 26569461 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrillation Testing (DT)
Number of subjects: 2500
Study 26569461 — intervention group
Group type: COMPARATOR
Intervention: No Defibrillation Testing (No DT)
Number of subjects: 2500
Study 26569461 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative Troponin Levels Above ULN (both DT and No DT)
Number of subjects: 2500
Study 26569461 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative Troponin Levels (both DT and No DT)
Number of subjects: 2500
Study 25100359 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone treatment for 36 months
Number of subjects: 108
Study 25100359 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch for 36 months
Number of subjects: 108
Study 22581698 — intervention group
Group type: EXPERIMENTAL
Intervention: CO₂ insufflation
Number of subjects: 180
Study 22581698 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 180
Study 20557819 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 22
Study 20557819 — intervention group
Group type: COMPARATOR
Intervention: Resistive training
Number of subjects: 22
Study 17586413 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 34
Study 17586413 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 34
Study 15918385 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with isoflurane/nitrous oxide (group General)
Number of subjects: 40
Study 15918385 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anaesthesia combined with isoflurane/nitrous oxide (group Integrated)
Number of subjects: 40
Study 15918385 — intervention group
Group type: COMPARATOR
Intervention: Comparison of heart rate
Number of subjects: 40
Study 15918385 — intervention group
Group type: COMPARATOR
Intervention: Comparison of mean arterial pressure
Number of subjects: 40
Study 14657746 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage
Number of subjects: 30
Study 14657746 — intervention group
Group type: COMPARATOR
Intervention: No closed suction drainage (Control)
Number of subjects: 30
Study 10533793 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFNalpha) treatment
Number of subjects: 18
Study 8649056 — intervention group
Group type: EXPERIMENTAL
Intervention: HDT plus ASCT
Number of subjects: 55
Study 8649056 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy (CT)
Number of subjects: 55
Study 1676238 — intervention group
Group type: EXPERIMENTAL
Intervention: bisoprolol
Number of subjects: 14
Study 1676238 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 7107353 — intervention group
Group type: COMPARATOR
Intervention: MISO alone
Number of subjects: 14
Study 7107353 — intervention group
Group type: EXPERIMENTAL
Intervention: MISO with DXM
Number of subjects: 14
Study 31817052 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous energy restriction
Number of subjects: 0
Study 31817052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction
Number of subjects: 0
Study 29780293 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G-CSF) followed by infusion of autologous mobilized peripheral blood mononuclear cells (mPBMCs)
Number of subjects: 16
Study 27059880 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral anodal and cathodal transcranial direct current stimulation (tDCS) applied to the left and right dorsolateral prefrontal cortex (dLPFC)
Number of subjects: 0
Study 27059880 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral tDCS over the dLPFC
Number of subjects: 0
Study 24655586 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga as add-on treatment
Number of subjects: 60
Study 24655586 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine fumarate extended release (QXR) 300 mg/day
Number of subjects: 60
Study 24655586 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (ESC) 10 mg/day
Number of subjects: 60
Study 24655586 — intervention group
Group type: COMPARATOR
Intervention: Cortisol improvers in week 1 of therapy
Number of subjects: 60
Study 22677580 — intervention group
Group type: EXPERIMENTAL
Intervention: StepStone Interactive Medical Software (SS)
Number of subjects: 30
Study 22677580 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture format (Control)
Number of subjects: 30
Study 21162438 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (n = 55) with one constraint
Number of subjects: 108
Study 21162438 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (n = 53) with three constraints
Number of subjects: 108
Study 21162438 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 17546332 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg iron sulfate alone (40 mg elemental iron) for 30 weeks
Number of subjects: 267
Study 17546332 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg iron sulfate plus 10,000 IU of vitamin A for 30 weeks
Number of subjects: 267
Study 17546332 — intervention group
Group type: COMPARATOR
Intervention: Comparison of mean Hb and anemia prevalence between groups
Number of subjects: 267
Study 15705659 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-(13)C-labeled l-leucine infusion
Number of subjects: 12
Study 12163729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical rib presence
Number of subjects: 324
Study 12163729 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacralization presence
Number of subjects: 324
Study 12163729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical rib with or without articulation
Number of subjects: 324
Study 12163729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical rib with articulation
Number of subjects: 324
Study 10088595 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic procedure
Number of subjects: 0
Study 10088595 — intervention group
Group type: COMPARATOR
Intervention: Two treatments
Number of subjects: 0
Study 8848187 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (15 mg daily)
Number of subjects: 20
Study 8848187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1970108 — intervention group
Group type: EXPERIMENTAL
Intervention: Autolymphocyte therapy (ALT) plus oral cimetidine
Number of subjects: 90
Study 1970108 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine alone
Number of subjects: 90
Study 1970108 — intervention group
Group type: EXPERIMENTAL
Intervention: Autolymphocyte therapy (ALT)
Number of subjects: 90
Study 7425360 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital 20 mg/kg, rectally
Number of subjects: 99
Study 7425360 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital 25 mg/kg, rectally
Number of subjects: 99
Study 7425360 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital 30 mg/kg, rectally
Number of subjects: 99
Study 7425360 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study 7425360 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital (all doses)
Number of subjects: 99
Study 30309264 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin levels at admission
Number of subjects: 393
Study 30309264 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin levels at discharge
Number of subjects: 393
Study 30309264 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin levels after 3 months
Number of subjects: 393
Study 30309264 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor binding protein-1 levels
Number of subjects: 393
Study 30309264 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin as a predictor of cardiovascular events
Number of subjects: 393
Study 30309264 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular events
Number of subjects: 393
Study 29039872 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent vitamin D supplementation
Number of subjects: 573
Study 29039872 — intervention group
Group type: EXPERIMENTAL
Intervention: Inconsistent vitamin D supplementation
Number of subjects: 573
Study 29039872 — intervention group
Group type: EXPERIMENTAL
Intervention: No vitamin D supplementation
Number of subjects: 573
Study 29039872 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 573
Study 24007304 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavoglurant (AFQ056) 25 mg bid to 100 mg bid
Number of subjects: 14
Study 24007304 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavoglurant (AFQ056)
Number of subjects: 14
Study 24007304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 25153733 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 14)
Number of subjects: 27
Study 25153733 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 13)
Number of subjects: 27
Study 22012805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 20
Study 19571161 — intervention group
Group type: EXPERIMENTAL
Intervention: quercetin+vitamin C (166mg+133mg/capsule)
Number of subjects: 20
Study 19571161 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐lipoic acid (300mg/capsule)
Number of subjects: 20
Study 19571161 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 17533206 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured pharmacist medication history interview with assessment and generation of a postoperative medication order form
Number of subjects: 464
Study 17533206 — intervention group
Group type: COMPARATOR
Intervention: Standard care (nurse‐conducted medication histories and surgeon‐generated medication orders)
Number of subjects: 464
Study 15302780 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in albuminuria
Number of subjects: 1513
Study 11347834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Enoxaparin)
Number of subjects: 36
Study 9389842 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 30
Study 9389842 — intervention group
Group type: COMPARATOR
Intervention: Uncuffed tracheal tube (TT)
Number of subjects: 30
Study 8255974 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline infusion (0.5-3.0 micrograms/min)
Number of subjects: 7
Study 8255974 — intervention group
Group type: COMPARATOR
Intervention: 25 mg atenolol (beta 1 antagonist)
Number of subjects: 7
Study 8255974 — intervention group
Group type: COMPARATOR
Intervention: 5 mg nadolol (beta 1/beta 2 blocker)
Number of subjects: 7
Study 8255974 — intervention group
Group type: COMPARATOR
Intervention: 80 mg nadolol (beta 1/beta 2 blocker)
Number of subjects: 7
Study 8255974 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline infusion
Number of subjects: 7
Study 3318433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone 1,000 mg at bedtime
Number of subjects: 40
Study 3318433 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 900 mg four times daily
Number of subjects: 40
Study 3318433 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 40
Study 3318433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 40
Study 29358034 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n=20) engaged in 20min of combined aerobic and coordinative exercise on each school day for eight weeks.
Number of subjects: 36
Study 29358034 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n=16) with no intervention.
Number of subjects: 36
Study 27486125 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin peglispro (BIL)
Number of subjects: 0